Skip to main content

The TRIAL Study

What care is offered to and accessed by people with acute pancreatitis after discharge and what are the opportunities to improve this?

Please watch our animation

Maecenas lacinia lobortis urna in egestas. Aliquam porttitor sit amet mi sit amet laoreet. Integer ex lectus, aliquet vitae neque id, hendrerit varius odio.

Background

Acute pancreatitis is a common condition that brings up to 40,000 people to hospitals each year in the UK.

They can be serious and sometimes become life-threatening. Acute pancreatitis are commonly due to gallstones and excess alcohol consumption. Most patients stay in hospital for up to a few weeks and then get discharged back home. However, about 8% of patients end up returning to the hospital within 30 days of their discharge, of whom one-in-three do not require hospital care. After being discharged, some patients continue to have health issues because their pancreas struggles to digest food or manage blood sugar. Moreover, half of those affected by acute pancreatitis are at risk of developing mental health issues such as anxiety or depression. Unfortunately, there is no standard follow up for this condition and its short & long term outcomes in UK. This may increase the cost of healthcare by missing opportunities for early detection and treatment of problems.

Taking Part

Find out more about taking part in the study

About the Study

Learn more about the study

Contact Us

Get in touch with the study team

Address
Morph Clinical Trial Unit
1 Morph St
Morphtown
Morphumbria MOR PH1

Telephone
0123-456-789

Email
[email protected]

Social
Twitter

The TRIAL study is funded by the National Institute for Health Research (project number MORPH12345). The views expressed are those of the authors and are not intended to be representative of the views of the funder, sponsor or other participating organisations.

Morph logo